Clinical severity of Alzheimer's disease is associated with PIB uptake in PET

被引:68
|
作者
Grimmer, Timo [1 ]
Henriksen, Gjermund [2 ]
Wester, Hans-Juergen [2 ]
Foerstl, Hans
Klunk, William E. [3 ]
Mathis, Chester A. [4 ]
Kurz, Alexander
Drzezga, Alexander [2 ]
机构
[1] Tech Univ Munich, Klinikum Rechts Isar, Klin & Poliklin Psychiat & Psychotherapie, Dept Psychiat & Psychotherapy, D-81675 Munich, Germany
[2] Tech Univ Munich, Klinikum Rechts Isar, Dept Nucl Med, D-81675 Munich, Germany
[3] Western Psychiat Inst & Clin, Dept Psychiat, Pittsburgh, PA 15213 USA
[4] Univ Pittsburgh, Dept Radiol, Pittsburgh, PA 15213 USA
关键词
Alzheimer's disease; Dementia; Clinical Dementia Rating; Amyloid plaques; Positron emission tomography; Imaging; 18F]FDG; 11C]PIB; Pittsburgh Compound B; CEREBRAL GLUCOSE-METABOLISM; PITTSBURGH COMPOUND-B; AMYLOID DEPOSITION; DEMENTIA; PLAQUES; BRAIN; AD; NEUROPATHOLOGY; DIAGNOSIS; CRITERIA;
D O I
10.1016/j.neurobiolaging.2008.01.016
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
Background: The positron emission tomography (PET) tracer [11C]-Pittsburgh Compound-B ([11C]PIB) allows the in vivo assessment of amyloid plaque burden in the brain. In a cross-sectional study we examined the association between the seventy of dementia assessed using the Clinical Dementia Rating scale sum of boxes (CDR-SOB) and [11C]PIB-PET in patients with Alzheimer's disease (AD). Methods: Patients with probable AD who had an AD-typical [18F]FDG-PET scan were included Linear regression analysis in anatomically defined regions-of-interest (ROIs) and correlation analysis using statistical parametric mapping (SPM) were used to determine the association between CDR-SOB and [11C]PIB uptake. Results: The linear regression analyses showed that the CDR-SOB explained approximately 11-22% of the variance of [11C]PIB uptake. The association attained statistical significance in both frontal, in both anterior cingulate cortices, and in both putamina. The SPM analysis showed a significant association in more widespread regions of the brain, with maxima located in similar areas as in the ROI-analysis. Conclusion: The CDR-SOB score is significantly associated with [11C]PIB uptake in patients with AD Thus [11C]PIB is a potential surrogate marker of dementia severity. (C) 2008 Elsevier Inc. All rights reserved.
引用
收藏
页码:1902 / 1909
页数:8
相关论文
共 50 条
  • [1] Clinically Different Stages of Alzheimer's Disease Associated by Amyloid Deposition with [11C]-PIB PET Imaging
    Hatashita, Shizuo
    Yamasaki, Hidetomo
    JOURNAL OF ALZHEIMERS DISEASE, 2010, 21 (03) : 995 - 1003
  • [2] In vivo imaging of astrocytosis in Alzheimer's disease: an 11C-L-deuteriodeprenyl and PIB PET study
    Santillo, Alexander Frizell
    Gambini, Juan Pablo
    Lannfelt, Lars
    Langstrom, Bengt
    Ulla-Marja, Luohija
    Kilander, Lena
    Engler, Henry
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2011, 38 (12) : 2202 - 2208
  • [3] Early detection of Alzheimer's disease using PiB and FDG PET
    Cohen, Ann D.
    Klunk, William E.
    NEUROBIOLOGY OF DISEASE, 2014, 72 : 117 - 122
  • [4] Multisite study of the relationships between antemortem [11C]PIB-PET Centiloid values and postmortem measures of Alzheimer's disease neuropathology
    La Joie, Renaud
    Ayakta, Nagehan
    Seeley, William W.
    Borys, Ewa
    Boxer, Adam L.
    Decarli, Charles
    Dore, Vincent
    Grinberg, Lea T.
    Huang, Eric
    Hwang, Ji-Hye
    Ikonomovic, Milos D.
    Jack, Clifford, Jr.
    Jagusth, William J.
    Jin, Lee-Way
    Klunk, William E.
    Kofler, Julia
    Lesman-Segev, Orit H.
    Lockhart, Samuel N.
    Lowe, Val J.
    Masters, Colin L.
    Mathis, Chester A.
    McLean, Catriona L.
    Miller, Bruce L.
    Mungas, Daniel
    O'Neil, James P.
    Olichney, John M.
    Parisi, Joseph E.
    Petersen, Ronald C.
    Rosen, Howard J.
    Rowe, Christopher C.
    Spina, Salvatore
    Vemuri, Prashanthi
    Villemagne, Victor L.
    Murray, Melissa E.
    Rabinovici, Gil D.
    ALZHEIMERS & DEMENTIA, 2019, 15 (02) : 205 - 216
  • [5] Negative 11C-PIB PET Predicts Lack of Alzheimer's Disease Pathology in Postmortem Examination
    Scheinin, Noora M.
    Gardberg, Maria
    Roytta, Matias
    Rinne, Juha O.
    JOURNAL OF ALZHEIMERS DISEASE, 2018, 63 (01) : 79 - 85
  • [6] PIB binding in aged primate brain: Enrichment of high-affinity sites in humans with Alzheimer's disease
    Rosen, Rebecca F.
    Walker, Lary C.
    LeVine, Harry, III
    NEUROBIOLOGY OF AGING, 2011, 32 (02) : 223 - 234
  • [7] Use of amyloid PET across the spectrum of Alzheimer's disease: clinical utility and associated ethical issues
    Leuzy, Antoine
    Zimmer, Eduardo Rigon
    Heurling, Kerstin
    Rosa-Neto, Pedro
    Gauthier, Serge
    AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS, 2014, 21 (03): : 143 - 148
  • [8] Identifying Mild Alzheimer's Disease With First 30-Min 11C-PiB PET Scan
    Shen, Chushu
    Wang, Zhenguo
    Chen, Hongzhao
    Bai, Yan
    Li, Xiaochen
    Liang, Dong
    Liu, Xin
    Zheng, Hairong
    Wang, Meiyun
    Yang, Yongfeng
    Wang, Haifeng
    Sun, Tao
    FRONTIERS IN AGING NEUROSCIENCE, 2022, 14
  • [9] Use of FDG PET as an imaging biomarker in clinical trials of Alzheimer's disease
    Herholz, Karl
    BIOMARKERS IN MEDICINE, 2012, 6 (04) : 431 - 439
  • [10] Early detection of Alzheimer disease 11C-PiB PET in twins discordant for cognitive impairment
    Scheinin, N. M.
    Aalto, S.
    Kaprio, J.
    Koskenvuo, M.
    Raiha, I.
    Rokka, J.
    Hinkka-Yli-Salomaki, S.
    Rinne, J. O.
    NEUROLOGY, 2011, 77 (05) : 453 - 460